Implantable Cardioverter Defibrillators (ICD)

September 9, 2014 — Use of a quadripolar left ventricular (LV) lead instead of a bipolar option during cardiac resynchronization therapy (CRT) can decrease complications at six months, according to preliminary hot line results presented at the 201...

August 11, 2014 — Medtronic announced it has received U.S. Food and Drug Administration (FDA) approval for the Attain Performa model 4298 quadripolar lead, and the Viva Quad XT and Viva Quad S cardiac resynchronization therapy defibrillators (CRT-...

May 23, 2014 — Medtronic announced the results from the first prospective randomized clinical trial to show that Medtronic implantable cardioverter-defibrillators (ICDs) can safely extend detection times before triggering therapy in secondary prev...

ICD Implants Heart Rhythm Society Clinical Study Insurance Male

A study presented at Heart Rhythm 2014, the Heart Rhythm Society’s 35th Annual Scientific Sessions, reports significant gender and health insurance disparities in implantable cardioverter defibrillator (ICD) procedures. ...

Cardiac Resynchonization Therapy (CRT), Implantable cardioverster defibrillators
Medtronic announced new results from the PainFree SST and Shock-Less clinical studies published in the journal HeartRhythm.
Biotronik announced the publication of new findings from the REPLACE Registry in Circulation: Arrhythmia and Electrophysiology. The Biotronik-...
Medtronic, Attain Performa, quadripolar leads
Medtronic Inc. announced the U.S. Food and Drug Administration (FDA) approval and commercial launch of two additional Attain Performa left ventricular (LV)...
implantable cardioverter defibrillator, ep lab, leads, implantable devices
A new study evaluating Optim-insulated implantable cardioverter defibrillator (ICD) leads found low rates of all-cause mechanical failure during a median...
Ecolab Healthcare's PD220 patient drape is the first to market specifically for Boston Scientific’s subcutaneous implantable cardioverter-
The CorMatrix Cardiovascular CorMatrix CanGaroo ECM Envelope is for use with cardiac implantable electronic devices (CIED’s) including...
Fysicon received approval from the U.S. Food and Drug Administration (FDA) to market Fysicon DataLinQ. The Fysicon DataLinQ products enable...
Medtronic received U.S. Food and Drug Administration (FDA) approval for the Attain Performa model 4298 quadripolar lead, and the Viva Quad...

Articles

Medtronic, Attain Performa, quadripolar leads
Medtronic Inc. announced the U.S. Food and Drug Administration (FDA) approval and commercial launch of two additional Attain Performa left ventricular (LV)...
September 9, 2014 — Use of a quadripolar left ventricular (LV) lead instead of a bipolar option during cardiac resynchronization therapy (CRT) can decrease...
May 23, 2014 — Medtronic announced the results from the first prospective randomized clinical trial to show that Medtronic implantable cardioverter-...
ICD Implants Heart Rhythm Society Clinical Study Insurance Male
A study presented at Heart Rhythm 2014, the Heart Rhythm Society’s 35th Annual Scientific Sessions, reports significant gender and health insurance...

Video Center

The silence is deafening. And since radiology associations, physician groups and vendors have yet...
2 days 8 hours ago
The America College of Cardiology has released its list of key late-breaking clinical trials at the...
1 week 3 days ago
As editor of DAIC, I keep a close watch on trends in cardiovascular technology and try to predict...
4 weeks 3 days ago
The webinar "State of the Art in MRI Pediatric Brain Perfusion Imaging" educates participants about the state of the art clinical and emerging translational...
This webinar discusses why contemporary adult cardiac interventions require significant ionizing radiation with potential health risks to both the patient and...
This webinar explained the benefits of better access, productivity and revenue cycle efficiency in a modern cardiovascular information system (CVIS...